Neuroepo multisession Phase II and III
A randomized, placebo-controlled clinical trial investigating the neuroprotective and neuromodulatory effects of intranasal NeuroEPO (erythropoietin) in Parkinson's disease patients. The dataset comprises multisession EEG recordings and clinical assessments collected at two timepoints: baseline (pre-intervention) and 9-month post-intervention, with the goal of examining whether NeuroEPO-related cognitive and motor effects are mediated by changes in EEG source activity and brain function.
- Participants
- 45
- Channels
- 21 (10-20)
- Size
- 476 MB
- Version
- vv1.0.0
- Updated
- Jul 22, 2026